Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
A standard treatment for endometrial cancer is chemotherapy and pembrolizumab together followed by pembrolizumab maintenance for two years. This treatment regimen has shown benefit in terms of delaying cancer progression in prior clinical trials, but the benefit of the pembrolizumab maintenance treatment and whether all participants need it is unclear. This research is being done on the maintenance portion of treatment to compare the efficacy between the combination of letrozole + abemaciclib an
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this endometrial cancer clinical trial in Boston, MA
If you're searching for endometrial cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.